HiFiBiO Therapeutics, a clinical stage global biotech company focusing on improving patient lives with single cell precision, announced that Fierce Biotech has named it as one of 2023’s “Fierce 15” biotechnology companies.
"We need to go early into the disease," insists AC Immune CEO Andrea Pfeifer. But pioneering a new treatment in a disease like Alzheimer's, where there's no conclusive evidence of what spurs the disease or how to treat it, is a devilishly complex task. "Honestly, nobody knows where th...
August 22 - Novartis:After cutting hundreds of jobs in New Jersey around the start of this year, the Big Pharma is at it again. Novartis plans to lay off 103 employees at its its U.S. headquarters in East Hanover, effective in November. The cut positions are in clinical operations as p...
据悉,这一裁员数量超过了全球员工总数的10¼研发团队成为被裁的重灾区,部分项目组或面临半数员工不再续约的情况。 Struggling Merck slashing 8,500 jobs in major R&D, commercial reorganization
Oct. 9 - Leo Pharma:The Danish dermatology biopharma is eliminating or relocating up to 250 roles. Most jobs affected by the move are based in Leo’s home country of Denmark and span all business areas.Story Oct. 8 - Black Diamond Therapeutics:The Cambridge, Massachusetts-based biotech has ...
The failure of balixafortide in phase 3 looks set to cost 29 people their jobs. Polyphor said it plans to “restructure” up to 29 positions. A consultation process with employees is underway. Polyphor called the cuts the “initial” restructuring. ...
making it the first new therapy approved for tuberculosis in 40 years. Janssen's Alzheimer's-targeting team-up with Pfizer ($PFE), bapineuzumab, was a colossal Phase III failure, leaving J&J to slash 130 jobs and rethink its strategy for the disease. But there was never any hesitation on ...
Innovation, like determination, is another term that regularly surfaces as Epstein discusses his work, not surprising from a man who considers Apple ($AAPL) founder Steve Jobs a role model. Epstein tries to be what he calls an "all in" leader, and anyone who aspires to that must do a ...